Predictors of Treatment Failure, Second-Line Therapy Outcomes, and Patient Satisfaction after Prostatic Artery Embolization: A Retrospective Study in Benign Prostatic Hyperplasia
Urologia Internationalis · 2025
DOI: 10.1159/000547152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Urologia Internationalis, 2025. Verfasst von Khaled Alghueiri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Helios Hospital Krefeld, Krefeld, Germany, khaled.alghueiri@protonmail.com. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Patient Satisfaction, Embolization, Therapeutic, Prostate. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
This study aims to evaluate the effectiveness of prostatic artery embolization (PAE) in treating benign prostatic hyperplasia (BPH), focusing on identifying the predictors of treatment failure and assessing patient satisfaction and second-line therapies for patients who undergo reoperation.
Methods
We conducted a monocentric, retrospective study involving 344 patients who underwent PAE from 2017 to 2022. The minimum follow-up time was 12 months. Baseline data were retrospectively collected. A single follow-up questionnaire was administered at the time of the study. Included patients were ≥50 years, with a prostate volume ≥40 mL, an International Prostate Symptom Score (IPSS) ≥8 and were unresponsive to medical therapy.
Results
Among 156 participants, the reoperation rate at 5 years was 28.2%. Baseline IPSS and post-void residual volumes (PVR) were significant predictors of therapy failure. Higher satisfaction was associated with younger age (p = 0.01), larger prostate volume (p = 0.02), and lower PVR (p = 0.03). Patients with higher satisfaction had better reoperation-free rates at 60 months (p = 0.002).
Conclusions
PAE is effective in reducing symptoms in patients with BPH; however, the reoperation rate emphasizes the importance of careful patient selection. Study limitations include potential selection bias, missing data, the single-center setting, and the use of a single follow-up questionnaire.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Helios Hospital Krefeld, Krefeld, Germany, khaled.alghueiri@protonmail.com.
- Department of Urology, University Medical Center Hamburg-Eppendorf (UKE), University of Hamburg, Hamburg, Germany, khaled.alghueiri@protonmail.com.
- Department of Urology, Pediatric Urology, and Andrology, University Hospital Giessen and Marburg, Giessen, Germany, khaled.alghueiri@protonmail.com.
- Department of Urology, Helios Hospital Krefeld, Krefeld, Germany.
- Department of Radiology, Helios Hospital Krefeld, Krefeld, Germany.
- Department of Urology, University Medical Center Hamburg-Eppendorf (UKE), University of Hamburg, Hamburg, Germany.
Zitieren
APA
Alghueiri, K., Engert, P. C., Alhabib, M., Schott, P., Arafat, W., Soave, A., & Friedrich, M. G. (2025). Predictors of Treatment Failure, Second-Line Therapy Outcomes, and Patient Satisfaction after Prostatic Artery Embolization: A Retrospective Study in Benign Prostatic Hyperplasia. Urologia Internationalis. https://doi.org/10.1159/000547152
Vancouver
Alghueiri K, Engert PC, Alhabib M, Schott P, Arafat W, Soave A, et al. Predictors of Treatment Failure, Second-Line Therapy Outcomes, and Patient Satisfaction after Prostatic Artery Embolization: A Retrospective Study in Benign Prostatic Hyperplasia. Urologia Internationalis. 2025. doi:10.1159/000547152
BibTeX
@article{Alghueiri2025,
author = {Alghueiri, Khaled and Engert, Philipp C and Alhabib, Mohamed and Schott, Peter and Arafat, Waseem and Soave, Armin and Friedrich, Martin G},
title = {Predictors of Treatment Failure, Second-Line Therapy Outcomes, and Patient Satisfaction after Prostatic Artery Embolization: A Retrospective Study in Benign Prostatic Hyperplasia},
journal = {Urologia Internationalis},
year = {2025},
doi = {10.1159/000547152}
}
EUVIMED